hero-pink

News

Press releases

April 26, 2022

Ambagon Therapeutics Appoints Gideon Bollag, Ph.D., to Scientific Advisory Board

January 6, 2022

Ambagon Therapeutics Launches with $85 Million Series A to Advance Pioneering Molecular Glue Platform and Progress Pipeline

Media Contact

Rhiannon Jeselonis
rhiannon@tenbridgecommunications.com

In The News

BioCentury | February 1, 2022

Ambagon: creating molecular glues for disordered proteins